Target intelligence / Profile preview

ribosomal protein S26 pseudogene 58 (RPS26P58)

Target: RPS26P58
Molecular classification: Other (Pseudogene), Not a member of \"protein-coding\" groups such as \"Receptor,\" \"Enzyme,\" or \"Transcription factor.\"

Overview

Ribosomal protein S26 pseudogene 58 (RPS26P58) is a non-functional genetic sequence similar to the ribosomal protein S26 gene, present in the human genome as a result of gene duplication and retrotransposition events. Pseudogenes like RPS26P58 do not encode functional proteins and generally have no well-characterized biological activity or direct disease relevance. The functional gene, ribosomal protein S26 (RPS26), codes for a structural component of the 40S ribosomal subunit, involved in protein synthesis and implicated in Diamond-Blackfan anemia when mutated[3][4][5][6]. RPS26P58 is among several dispersed pseudogenes of RPS26 and is not considered a therapeutic target or biomarker.

Other names: RPS26P58ribosomal protein S26 pseudogene 58

Mechanism of action

None (Not applicable for pseudogenes which do not produce protein)

Biological functions

Other (None; no known biological function as it is a pseudogene)Functional biological roles pertain only to the active RPS26 gene

Disease associations

Other (None for RPS26P58; see below for RPS26 disease relevance)Pseudogenes generally do not have direct disease roles, but mutations in the functional RPS26 gene cause Diamond-Blackfan anemia

Safety considerations

None (No safety or therapeutic concerns noted for pseudogenes)

Interacting drugs

None (No drugs interact with RPS26P58; no data for pseudogene-specific drugs)

Biomarkers

None (Pseudogene-specific sequences may be used in genomics, but not as clinical biomarkers for patient selection or efficacy monitoring)

Beyond the preview

Go deeper on ribosomal protein S26 pseudogene 58 (RPS26P58).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ribosomal protein S26 pseudogene 58 (RPS26P58).

Explore the full profile